Patient preference for second and third line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

Patient preference is key for medication selection in chronic medical conditions, like type 2 diabetes, where there are many different drugs available. Patient preference balances potential efficacy with potential side effects. As both aspects of drug response can vary markedly between individuals t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Beverley M, Angwin, Catherine D, Shepherd, Maggie H, Britten, Nicky, Jones, Angus G, Sattar, Naveed, Holman, Rury, Pearson, Ewan R, Hattersley, Andrew T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614215/
https://www.ncbi.nlm.nih.gov/pubmed/36477734
http://dx.doi.org/10.1038/s41591-022-02121-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614215/
https://www.ncbi.nlm.nih.gov/pubmed/36477734
http://dx.doi.org/10.1038/s41591-022-02121-6

Ejemplares similares